Fernández F, Domingo C, Amgarou K, Castelo J, Bouassoule T, Garcia M J, Luguera E
Grup de Física de les Radiacions, Departament de Física, Universitat Autónoma de Barcelona, E-08193 Bellaterra, Spain.
Radiat Prot Dosimetry. 2007;126(1-4):361-5. doi: 10.1093/rpd/ncm075. Epub 2007 May 24.
The use of high-energy linear electron accelerators (LINACs) for medical cancer treatments is widespread on an international scale. The associated bremsstrahlung X rays may produce neutrons as a result of subsequent photonuclear reactions with the different materials constituting the accelerator head. The generated neutron field is highly variable and depends strongly on the beam energy, on the accelerator shielding, on the flattering filter as well as on the movable collimators (jaws) design and on the irradiation field geometry. An estimate of this photoneutron component is, thus, of practical interest to quantify the radiological risk for the working staff and patients. Due to high frequency electromagnetic fields, and also to the presence of abundant leaked and scattered photons in these installations, measurements of the corresponding neutron fields by active dosemeters are extremely difficult. A modified version of the Bonner sphere system, based on passive gold activation detectors, has been used to perform neutron measurements at two points in a Varian 2,100C LINAC facility. A home-made unfolding procedure (CDM) has been utilised to determine the neutron spectra present at the measurement points. Results indicate that the giant dipole resonance process is the most adequate model to explain neutron production in the LINAC and that a thermal component is present at the measurement points.
高能线性电子加速器(LINAC)在国际范围内广泛应用于医学癌症治疗。相关的轫致辐射X射线可能会因随后与构成加速器头部的不同材料发生光核反应而产生中子。所产生的中子场变化很大,并且强烈依赖于束流能量、加速器屏蔽、扁平滤过器以及活动准直器(光阑)设计和照射野几何形状。因此,对这种光中子成分进行估算对于量化工作人员和患者的放射风险具有实际意义。由于存在高频电磁场,以及这些装置中存在大量泄漏和散射光子,使用有源剂量计测量相应的中子场极其困难。一种基于无源金活化探测器的改进型邦纳球系统已被用于在瓦里安2100C LINAC设施的两个点进行中子测量。已采用自制的解谱程序(CDM)来确定测量点处存在的中子能谱。结果表明,巨偶极共振过程是解释LINAC中中子产生的最合适模型,并且在测量点处存在热成分。